BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11315326)

  • 21. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
    Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
    Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma: a minimally invasive means to nephron preservation.
    Blitstein J; Ghavamian R
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):921-7. PubMed ID: 18533801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of margin in nephron sparing surgery for renal cell carcinoma of 4 cm or less.
    Li QL; Guan HW; Wang FP; Jiang T; Wu HC; Song XS
    Chin Med J (Engl); 2008 Sep; 121(17):1662-5. PubMed ID: 19024095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases.
    Duvdevani M; Laufer M; Kastin A; Mor Y; Nadu A; Hanani J; Nativ O; Ramon J
    J Urol; 2005 Feb; 173(2):385-7. PubMed ID: 15643176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephron-sparing surgery. Reproducibility of results, personal cases, and comparison with the international literature].
    Seveso M; Taverna GL; Maffezzini M; Giusti G; Benetti A; Graziotti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):65-8. PubMed ID: 12161939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
    Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
    Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of nephron preservation in conservative surgery of renal tumors].
    Lebret T; Pruna A; Pollux C; Hervé JM; Barré P; Gaudez F; Botto H
    Ann Urol (Paris); 1997; 31(3):145-9. PubMed ID: 9273844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephron-sparing surgery for renal cell carcinoma of the allograft after renal transplantation: report of two cases.
    Tuzuner A; Çakir F; Akyol C; Çelebi ZK; Ceylaner S; Ceylaner G; Sengül S; Keven K
    Transplant Proc; 2013 Apr; 45(3):958-60. PubMed ID: 23622598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of nephron sparing surgery for renal cancer].
    Meyer G; Mullerad M; Nativ O
    Harefuah; 2003 Mar; 142(3):208-11, 237. PubMed ID: 12696476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort.
    Ploussard G; Chambade D; Meria P; Gaudez F; Tariel E; Verine J; De Bazelaire C; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    BJU Int; 2012 Jan; 109(2):195-9. PubMed ID: 21810160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Our experience with nephron-sparing surgery in the past nine years].
    Könyves K; Engert Z; Molnár I; Pánykó E; Varga L; Farkas J; Márkus E; Hajós G; Scheid S; Rajnai I
    Orv Hetil; 2009 Aug; 150(33):1563-7. PubMed ID: 19643722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery.
    Raz O; Mendlovic S; Shilo Y; Leibovici D; Sandbank J; Lindner A; Zisman A
    Urology; 2010 Feb; 75(2):277-80. PubMed ID: 19896179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A national study of kidney graft tumor treatments: Toward ablative therapy.
    Guleryuz K; Doerfler A; Codas R; Coffin G; Hubert J; Lechevallier E; Tillou X;
    Surgery; 2016 Jul; 160(1):237-244. PubMed ID: 27032620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma.
    Berdjis N; Hakenberg OW; Zastrow S; Oehlschläger S; Novotny V; Wirth MP
    BJU Int; 2006 Jun; 97(6):1208-10. PubMed ID: 16686712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephron-sparing surgery for renal cell carcinoma with venous involvement.
    Angermeier KW; Novick AC; Streem SB; Montie JE
    J Urol; 1990 Dec; 144(6):1352-5. PubMed ID: 2231924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic nephron-sparing surgery for two or more ipsilateral renal tumors.
    Steinberg AP; Kilciler M; Abreu SC; Ramani AP; Ng C; Desai MM; Kaouk JH; Gill IS
    Urology; 2004 Aug; 64(2):255-8. PubMed ID: 15302473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal cell carcinoma: risks and benefits of nephron-sparing surgery for T1 tumors.
    Ghandour RA; Danzig MR; McKiernan JM
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):258-65. PubMed ID: 26088069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.